Evidence mapPaperPMID 42539151Full record

ArticlebioRxiv : the preprint server for biology2026

Graph in Graph (GiG): A novel graph AI framework for integrating and interpreting medical and omics data.

Heming Zhang, Yifei Lu, Kaiwen Fang, Zixi Xu, Vaha Akabry Moghaddam, Ping An, Shiow Jin, Mary Wojczynski, Michael Province, Fuhai Li

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Heming ZhangInstitute for Informatics (I2), Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-2025-9090
Yifei LuInstitute for Informatics (I2), Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.ORCID 0009-0002-6248-4867
Kaiwen FangInstitute for Informatics (I2), Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.ORCID 0009-0002-1211-4008
Zixi XuInstitute for Informatics (I2), Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.ORCID 0009-0001-6858-0916
Vaha Akabry MoghaddamDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Ping AnDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Shiow JinDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Mary WojczynskiDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Michael ProvinceDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Fuhai LiInstitute for Informatics (I2), Washington University School of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-3773-146X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical records and omics data are rapidly becoming standard in healthcare settings, which characterize the whole-person from dysfunctional molecules to phenotypes, and thus offer potential for precise disease diagnosis and target discovery. Whereas, it remains an open problem to systematically integrate and interprete medical record and omics data of individual patients. In this study, for the first time, we propose a novel graph AI model framework, Graph in Graph (GiG), to integrate and interpret the whole-person medical and omic datasets. Specifically, the medical record data is modeled using a person-phenotype graph, followed by omics signaling graphs of invidival patients, which enables the integration of information learned from omic-signaling graph and medical phenotype features to characterize individual patients and to prioritize important omic biomarkers and phenotypes. As an exploratory study, we applied and evaluated the GiG model to study the type 2 diabetes (T2D) and pre-T2D vs healthy using the Long Life Family Study (LLFS) cohort, which enrolls families with exceptional longevity to uncover biological mechanisms of healthy aging with medical and omics data. The evaluation results showed that GiG not only achieve a high prediction but also can interpret the prediction by ranking the essential clinical and omic biomarkers. The GiG framework can be applied to other studies by effectively integrating and interpreting medical and omic datasets for disease diagnosis and pathogenesis discovery.

Identifiers

PMID42539151
PMCPMC13419737

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.